[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Boddupalli, C.S. and Ghosh, S. and Rahim, S.C. and Nair, S. and Ehtesham, N.Z. and Hasnain, S.E. and Mukhopadhyay, Sangita (2007) Nitric oxide inhibits interleukin-12 p40 through p38 MAPK-mediated regulation of calmodulin and c-rel. Free Radical Biology and Medicine, 42 (5). pp. 686-697. ISSN 0891-5849

[img] Text
Free Radical Biol 42 p686.pdf
Restricted to Repository staff only

Download (671Kb) | Request a copy

Abstract

In activated macrophages, the rel/NF-κB transcription factors are known to play important roles in interleukin-12 (IL-12) p40 regulation by nitric oxide (NO). However, the relative contributions of these factors are not well understood. Here, we describe a dominant role for c-rel involving p38 mitogen-activated protein kinase (p38 MAPK) and calmodulin (CaM) protein in NO-mediated IL-12 p40 inhibition in activated macrophages. Inhibition of NO production by aminoguanidine increased, whereas sodium nitroprusside (SNP; an exogenous NO generator) reduced, nuclear c-rel levels in LPS + IFN-γ-activated RAW 264.7 macrophages. Overexpression of c-rel but not p65 NF-κB increased IL-12 p40 during NO treatment. The p38 MAPK phosphorylation is increased by NO, and inhibition of p38 MAPK in SNP-treated macrophages by SB203580 or transient expression of a dominant-negative mutant of p38 MAPK upregulated both nuclear c-rel and IL-12 p40 levels, indicating that NO targeted the p38 MAPK pathway to inhibit c-rel and IL-12 p40. Cytoplasmic CaM level was increased by NO, and SB203580 decreased the CaM level in NO-exposed macrophages. Inhibition of CaM activity by trifluoperazine rescued the inhibitory effect of NO on c-rel and IL-12 p40. Our findings indicate that c-rel plays an important role in NO-mediated inhibition of IL-12 p40 and is regulated by p38 MAPK through CaM protein.

Item Type: Article
Depositing User: Users 2 not found.
Date Deposited: 17 Aug 2015 06:48
Last Modified: 17 Aug 2015 06:48
URI: http://cdfd.sciencecentral.in/id/eprint/345

Actions (login required)

View Item View Item